ATE167662T1 - Verfahren zur herstellung eines lignan-derivats - Google Patents

Verfahren zur herstellung eines lignan-derivats

Info

Publication number
ATE167662T1
ATE167662T1 AT94912092T AT94912092T ATE167662T1 AT E167662 T1 ATE167662 T1 AT E167662T1 AT 94912092 T AT94912092 T AT 94912092T AT 94912092 T AT94912092 T AT 94912092T AT E167662 T1 ATE167662 T1 AT E167662T1
Authority
AT
Austria
Prior art keywords
compound
general formula
producing
lower alkyl
cycloalkyl
Prior art date
Application number
AT94912092T
Other languages
German (de)
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE167662T1 publication Critical patent/ATE167662T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
AT94912092T 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats ATE167662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
ATE167662T1 true ATE167662T1 (de) 1998-07-15

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912092T ATE167662T1 (de) 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats

Country Status (13)

Country Link
US (1) US5488134A (enFirst)
EP (1) EP0646570B1 (enFirst)
JP (1) JP3411036B2 (enFirst)
KR (1) KR100277242B1 (enFirst)
CN (1) CN1046937C (enFirst)
AT (1) ATE167662T1 (enFirst)
AU (1) AU666819B2 (enFirst)
CA (1) CA2138264C (enFirst)
DE (1) DE69411243T2 (enFirst)
DK (1) DK0646570T3 (enFirst)
ES (1) ES2119190T3 (enFirst)
TW (1) TW255886B (enFirst)
WO (1) WO1994024087A1 (enFirst)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
RU2198885C2 (ru) 1997-09-29 2003-02-20 Мейдзи Сейка Кайся Лтд. Производные трициклического триазолобензазепина, способы их получения, фармацевтическая композиция и способ лечения аллергических заболеваний, промежуточные соединения и способы их получения
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
EP1140190B1 (en) 1998-12-23 2002-11-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
ATE240120T1 (de) 1998-12-23 2003-05-15 Searle Llc Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
IL143949A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
DK1140185T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
WO2000038726A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
US20020061888A1 (en) * 2000-03-10 2002-05-23 Keller Bradley T. Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
JP2005518347A (ja) 2001-11-02 2005-06-23 ジー.ディー. サール エルエルシー 頂端ナトリウム共依存性胆汁酸輸送(asbt)およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
BR0306643A (pt) 2002-01-17 2004-10-19 Pharmacia Corp Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
US20140323412A1 (en) 2011-10-28 2014-10-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
SG10201909122QA (en) 2011-10-28 2019-11-28 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
CA2907214A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
JP7562546B2 (ja) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0701991T3 (da) * 1991-10-17 1999-09-13 Shionogi & Co Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Also Published As

Publication number Publication date
ES2119190T3 (es) 1998-10-01
JP3411036B2 (ja) 2003-05-26
AU6437994A (en) 1994-11-08
KR950701902A (ko) 1995-05-17
KR100277242B1 (ko) 2001-02-01
DE69411243T2 (de) 1998-11-19
CA2138264A1 (en) 1994-10-27
DE69411243D1 (de) 1998-07-30
EP0646570A1 (en) 1995-04-05
US5488134A (en) 1996-01-30
AU666819B2 (en) 1996-02-22
CN1046937C (zh) 1999-12-01
CN1109685A (zh) 1995-10-04
EP0646570A4 (en) 1995-08-09
WO1994024087A1 (fr) 1994-10-27
CA2138264C (en) 2004-04-06
TW255886B (enFirst) 1995-09-01
EP0646570B1 (en) 1998-06-24
DK0646570T3 (da) 1998-10-26

Similar Documents

Publication Publication Date Title
DE69411243D1 (de) Verfahren zur herstellung eines lignan-derivats
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69304309D1 (de) Verfahren zur herstellung von taxan-derivaten
DE69513367D1 (de) Vitamin d3 derivat und verfahren zu dessen herstellung
DE69319764D1 (de) Verfahren zur Herstellung von Beta-Lactamderivaten und Zwischenprodukt für ihre Synthese
ATE141295T1 (de) Verfahren zur herstellung eines styrol-polymers
DE69707341D1 (de) Verfahren zur Herstellung von 4-Aryl-3-Hydroxymethyl-piperidinen
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
ATE131169T1 (de) 2-pyranon-derivat und verfahren zu dessen herstellung.
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
DE69427978D1 (de) Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates
ATE236109T1 (de) Verfahren zur herstellung von 1,5-pentandiol- derivaten
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
ATE131483T1 (de) Verfahren zur herstellung von penemen
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS
ATE277064T1 (de) Verfahren zur herstellung von vinylpyrimidinderivaten
FI915109A0 (fi) Foerfarande foer framstaellning av alifatisk amid och salter daerav.
ATE157357T1 (de) Verfahren zur herstellung von dihydrofuranonderivaten
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür
DE69132547D1 (de) Verfahren zur herstellung von azacycloalkanderivaten
ATE92029T1 (de) Verfahren zur herstellung von 2-cyclohexenylcarboxylaten.
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee